Englander Institute for Precision Medicine
Found 877 results
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2023
Guilbaud E, Kroemer G, Galluzzi L.  2023.  Calreticulin exposure orchestrates innate immunosurveillance.. Cancer Cell. 41(6):1014-1016.
Galassi C, Galluzzi L.  2023.  Cancer stem cell immunoediting by IFNγ.. Cell Death Dis. 14(8):538.
Galluzzi L, Myint M.  2023.  Cell death and senescence.. J Transl Med. 21(1):425.
Weiss TJ, Crawford ER, Posada V, Rahman H, Liu T, Murphy BM, Arnold TE, Gray S, Hu Z, Hennessey RC et al..  2023.  Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melanin.. Pigment Cell Melanoma Res. 36(1):6-18.
Klapp V, Buqué A, Bloy N, Sato A, Yamazaki T, Zhou XKathy, Formenti SC, Galluzzi L, Petroni G.  2023.  Cellular senescence in the response of HR breast cancer to radiotherapy and CDK4/6 inhibitors.. J Transl Med. 21(1):110.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2023.  ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. bioRxiv.
Higano CS, George DJ, Shore ND, Sartor O, Miller K, Conti PS, Sternberg CN, Saad F, Sade JPablo, Bellmunt J et al..  2023.  Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer.. EClinicalMedicine. 60:101993.
Agarwal PK, Sternberg CN.  2023.  Clinical Trials Corner Issue 9 (2). Bladder Cancer. 9(2):187-190.
Agarwal PK, Sternberg CN.  2023.  Clinical Trials Corner Issue 9 (4). Bladder Cancer. 9(4):377-381.
Meleshko D, Prjbelski AD, Raiko M, Tomescu AI, Tilgner H, Hajirasouliha I.  2023.  cloudrnaSPAdes: Isoform assembly using bulk barcoded RNA sequencing data.. bioRxiv.
Shah SB, Carlson CR, Lai K, Zhong Z, Marsico G, Lee KM, Vélez NEFélix, Abeles EB, Allam M, Hu T et al..  2023.  Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas.. Nat Mater. 22(4):511-523.
Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk RF.  2023.  Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy.. medRxiv.
Orme JJ, Taza F, De Sarkar N, Tewari AK, Naqvi SArsalan, Riaz IB, Childs DS, Omar N, Adra N, Ashkar R et al..  2023.  Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.. Eur Urol Oncol.
Huang SH, Sartorello G, Shen P-T, Xu C, Elemento O, Shvets G.  2023.  Correction: Metasurface-enhanced infrared spectroscopy in multiwell format for real-time assaying of live cells.. Lab Chip. 23(17):3893.
Popic V, Rohlicek C, Cunial F, Hajirasouliha I, Meleshko D, Garimella K, Maheshwari A.  2023.  Cue: a deep-learning framework for structural variant discovery and genotyping.. Nat Methods. 20(4):559-568.
Liu W, Newhall KP, Khani F, Barlow LM, Nguyen D, Gu L, Eng K, Bhinder B, Uppal M, Récapet C et al..  2023.  The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.. Cancer Res. 83(4):506-520.
Hussain M, Tombal B, Saad F, Fizazi K, Sternberg CN, E Crawford D, Shore N, Kopyltsov E, Kalebasty ARezazadeh, Bögemann M et al..  2023.  Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.. J Clin Oncol. 41(20):3595-3607.
Assaad MAl, Shin N, Sigouros M, Manohar J, Antysheva Z, Kotlov N, Kiriy D, Nikitina A, Kleimenov M, Tsareva A et al..  2023.  Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.. Front Oncol. 13:1274163.
Yao P, Witte D, German A, Periyakoil P, Kim YEun, Gimonet H, Sulica L, Born H, Elemento O, Barnes J et al..  2023.  A deep learning pipeline for automated classification of vocal fold polyps in flexible laryngoscopy.. Eur Arch Otorhinolaryngol.
Darabedian N, Ji W, Fan M, Lin S, Seo H-S, Vinogradova EV, Yaron TM, Mills EL, Xiao H, Senkane K et al..  2023.  Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor.. Nat Chem Biol. 19(7):815-824.
Yusupova M, Zhou D, You J, Gonzalez-Guzman J, Ghanta MB, Pu H, Abdel-Malek Z, Chen Q, Gross SS, D'Orazio J et al..  2023.  Distinct cAMP signaling microdomains differentially regulate melanosomal pH and pigmentation.. J Invest Dermatol.
Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L.  2023.  The DNA Damage Response and Inflammation in Cancer.. Cancer Discov. 13(7):1521-1545.
Mirjolet C, Baude J, Galluzzi L.  2023.  Dual impact of radiation therapy on tumor-targeting immune responses.. Int Rev Cell Mol Biol. 378:xiii-xxiv.
Merdler-Rabinowicz R, Gorelik D, Park J, Meydan C, Foox J, Karmon M, Roth HS, Cohen-Fultheim R, Shohat-Ophir G, Eisenberg E et al..  2023.  Elevated A-to-I RNA editing in COVID-19 infected individuals.. NAR Genom Bioinform. 5(4):lqad092.
Galluzzi L, Aryankalayil MJ, C Coleman N, Formenti SC.  2023.  Emerging evidence for adapting radiotherapy to immunotherapy.. Nat Rev Clin Oncol.